Autoimmune hepatitis type 2 following anti-papillomavirus vaccination in a 11-year-old girl

How much more evidence are we going to need to see before we say that we registered this dangerous vaccination before we had any idea of the many autoimmune conditions it would cause? It’s time to withdraw Gardasil and Cervarix from the market.

Claudia Della Cortea,1, Antonio Carluccib,2, Paola Francalancic,3, Anna Alisia,4, Valerio Nobilia,∗

Vaccine 29 (2011) 4654–4656

In the last years numerous reports describing a possible association between administration of vaccines and development of autoimmune phenomena and overt autoimmune disease were published. Possible mechanisms of induction of autoimmune phenomena by vaccines and their excipients are probably similar to those implicated in induction by infectious agents.

Here we report the case of an 11-year-old girl who developed autoimmune hepatitis type II after four weeks from vaccination against human papillomavirus.

The possible relationships between the use of adjuvated vaccine against papillomavirus and autoim- mune hepatitis are discussed.

Although we do not provide evidence for a causal link, we suggest that the occurrence of the autoim- mune hepatitis may be related to the stimulation of immune system by adjuvated-vaccine, that could have triggered the disease in a genetically predisposed individual.

Therefore a monitoring of liver function test following administration of vaccine against papillomavirus may be useful in adolescent girl with signs of hepatopathy, as jaundice, dark urine or hepatomegaly, to early identify and to promptly treat autoimmune liver disorders.